Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harren Jhoti

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Nature Biotechnology|February 8, 2005
A new school for screeningHarren Jhoti
Drug Discovery Today|December 12, 2001
Structural genomics: lessons to be learntHarren Jhoti
Drug Discovery Today|May 2, 2002
Structure-based screening of low-affinity compoundsRobin Carr, Harren Jhoti
Current Opinion in Chemical Biology|June 27, 2003
High-throughput crystallography to enhance drug discoveryAndrew Sharff, Harren Jhoti
Expert Opinion on Drug Discovery|November 12, 2013
High-throughput screening and structure-based approaches to hit discovery: is there a clear winner?Harren Jhoti, Stephen Rees, Roberto Solari
Chembiochem : a European Journal of Chemical Biology|February 8, 2005
The discovery of novel protein kinase inhibitors by using fragment-based high-throughput x-ray crystallographyAdrian Gill, Anne Cleasby, Harren Jhoti
Nature Reviews. Drug Discovery|July 18, 2002
High-throughput crystallography for lead discovery in drug designTom L Blundell, Harren Jhoti, Chris Abell
Current Opinion in Chemical Biology|September 14, 2007
Fragment-based screening using X-ray crystallography and NMR spectroscopyHarren Jhoti, Anne Cleasby, Marcel Verdonk, et al.
Drug Discovery Today|October 14, 2003
A 'rule of three' for fragment-based lead discovery?Miles Congreve, Robin Carr, Chris Murray, et al.
Nature Reviews. Drug Discovery|July 13, 2013
The 'rule of three' for fragment-based drug discovery: where are we now?Harren Jhoti, Glyn Williams, David C Rees, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Nature Biotechnology|February 8, 2005
A new school for screeningHarren Jhoti
Drug Discovery Today|December 12, 2001
Structural genomics: lessons to be learntHarren Jhoti
Drug Discovery Today|May 2, 2002
Structure-based screening of low-affinity compoundsRobin Carr, Harren Jhoti
Current Opinion in Chemical Biology|June 27, 2003
High-throughput crystallography to enhance drug discoveryAndrew Sharff, Harren Jhoti
Expert Opinion on Drug Discovery|November 12, 2013
High-throughput screening and structure-based approaches to hit discovery: is there a clear winner?Harren Jhoti, Stephen Rees, Roberto Solari
Chembiochem : a European Journal of Chemical Biology|February 8, 2005
The discovery of novel protein kinase inhibitors by using fragment-based high-throughput x-ray crystallographyAdrian Gill, Anne Cleasby, Harren Jhoti
Nature Reviews. Drug Discovery|July 18, 2002
High-throughput crystallography for lead discovery in drug designTom L Blundell, Harren Jhoti, Chris Abell
Current Opinion in Chemical Biology|September 14, 2007
Fragment-based screening using X-ray crystallography and NMR spectroscopyHarren Jhoti, Anne Cleasby, Marcel Verdonk, et al.
Drug Discovery Today|October 14, 2003
A 'rule of three' for fragment-based lead discovery?Miles Congreve, Robin Carr, Chris Murray, et al.
Nature Reviews. Drug Discovery|July 13, 2013
The 'rule of three' for fragment-based drug discovery: where are we now?Harren Jhoti, Glyn Williams, David C Rees, et al.
Pageof 3